Answers are grounded in this paper and cite their sources.
This case report reveals allergic bronchopulmonary mycosis in a postoperative lung cancer patient, highlighting diagnostic challenges and treatment implications.
Rationale: Schizophyllum commune (S commune ), a basidiomycetous fungus, is increasingly recognized as an important cause of allergic bronchopulmonary mycosis, particularly in immunocompetent individuals with a history of respiratory surgery, chronic sinusitis, or structural airway abnormalities. Patient concerns: A 71-year-old female with a prior right upper lobectomy for lung cancer and a history of invasive fungal sinusitis presented with recurrent dyspnea, cough, and chest tightness. Diagnoses: The diagnosis was confirmed by fungal culture and 18S rRNA sequencing, along with significantly elevated total serum immunoglobulin E (541 IU/mL), specific immunoglobulin E to S commune (15.2 kU/L), and peripheral eosinophilia (8.0%). Interventions: The patient was treated with voriconazole and inhaled corticosteroids/formoterol for asthma control. Outcomes: Marked improvement in symptoms and radiologic findings was observed after 1 month of treatment, with sustained improvement over 3 months. Lessons: This case highlights the diagnostic challenges in distinguishing S commune –induced allergic bronchopulmonary mycosis and emphasizes the importance of considering this pathogen even in immunocompetent patients.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: